NEW GAMMA INNOVATION Trademark
Trademark Overview
On Thursday, September 30, 2021, a trademark application was filed for NEW GAMMA INNOVATION with the United States Patent and Trademark Office. The USPTO has given the NEW GAMMA INNOVATION trademark a serial number of 97053710. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Monday, January 23, 2023. This trademark is owned by New Beta Innovation Limited. The NEW GAMMA INNOVATION trademark is filed in the Computer & Software Services & Scientific Services category with the following description:
Biological research; chemical research; clinical trials; medical research; scientific research; biotechnology research; biotechnology testing; conducting clinical trials; conducting clinical trials for pharmaceutical products; conducting early evaluations in the field of new pharmaceuticals; development of pharmaceutical preparations and medicines; inspection of pharmaceuticals; laboratory research services relating to pharmaceuticals; laboratory research services relating to pharmaceuticals; medical research laboratory services; providing information about the results of clinical trials for pharmaceutical products; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; research of pharmaceuticals; research on the subject of pharmaceuticals; services for assessing the efficiency of pharmaceuticals; testing of pharmaceuticals; des...
General Information
Serial Number | 97053710 |
Word Mark | NEW GAMMA INNOVATION |
Filing Date | Thursday, September 30, 2021 |
Status | 602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE |
Status Date | Monday, January 23, 2023 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
Goods and Services | Biological research; chemical research; clinical trials; medical research; scientific research; biotechnology research; biotechnology testing; conducting clinical trials; conducting clinical trials for pharmaceutical products; conducting early evaluations in the field of new pharmaceuticals; development of pharmaceutical preparations and medicines; inspection of pharmaceuticals; laboratory research services relating to pharmaceuticals; laboratory research services relating to pharmaceuticals; medical research laboratory services; providing information about the results of clinical trials for pharmaceutical products; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; research of pharmaceuticals; research on the subject of pharmaceuticals; services for assessing the efficiency of pharmaceuticals; testing of pharmaceuticals; design and development of medical diagnostic apparatus |
Classification Information
International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Thursday, October 28, 2021 |
Primary Code | 042 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
Party Name | New Beta Innovation Limited |
Party Type | 10 - Original Applicant |
Legal Entity Type | 99 - Other |
Address | Hong Kong HK |
Trademark Events
Event Date | Event Description |
Monday, January 23, 2023 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND |
Monday, January 23, 2023 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND |
Monday, January 23, 2023 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
Thursday, July 7, 2022 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Thursday, July 7, 2022 | NON-FINAL ACTION E-MAILED |
Thursday, July 7, 2022 | NON-FINAL ACTION WRITTEN |
Thursday, June 30, 2022 | ASSIGNED TO EXAMINER |
Thursday, October 28, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Monday, October 4, 2021 | NEW APPLICATION ENTERED |